HPV16 E6-E7 Induces Cancer Stem-like Cell Phenotypes and Chemoradioresistance in Esophageal Squamous Cell Carcinoma Through Activation of PI3K/Akt Signaling Pathway
S. Che,R. Xi,S. Pan,X. Chen,B. Hui,S. Fu,J. Guo,X. Zhang
DOI: https://doi.org/10.1016/j.ijrobp.2016.06.2027
2016-01-01
Abstract:High-risk human papillomavirus (HPV), especially HPV16, is correlates with carcinogenesis of human esophageal squamous cell carcinoma (ESCC) in China as well as other Asia-Pacific regions. In our previous study HPV16 infection related with a poor prognosis of ESCC patients in China. The aim of this study is to investigate the potential role and mechanism of HPV16 in ESCC development and progress. The carcinogenic viral E6-E7 lentiviral vector was transfected into Eca109 and TE-1 cells, which labeled as Eca109-psb and TE-1-psb cells. The expression of HPV16 E6-E7 was confirmed by Western blotting. Both Eca109-psb and TE-1-psb cells were tested for cancer stem-like cells (CSCs) properties, including migration and invasion assays, spherogenesis ability assay, as well as Cell viability assay in vitro. Flow cytometry was performed to detect the ratio of p75NTR+ cells, cells apoptosis and cells cycles in ESCC cells. Colony formation assay was used to evaluate radiation sensibility. CCK-8 assay was performed to determine chemo-sensibility. Western blotting and immunofluorescence were used to detect the expression level of HPV16 E6, p75NTR, PI3K, Akt and P-Akt proteins. The xenograft nude mouse model was established to verify the effects of HPV16 E6-E7 on tumorigenesis in ESCC cells in vivo. Immunohistochemical staining was performed to investigate PI3K, Akt, and P-Akt expression in tissue. In both Eca109-psb and TE-1-psb cells HPV16 E6-E7 protein was stably expressed. It was demonstrated that both Eca109-psb and TE-1-psb cells had remarkable cancer stem-like cells (CSCs) properties, including stronger abilities of migration, invasion, spherogenesis, anti-apoptosis, higher expression of ESCC CSCs marker p75NTR, more resistance to chemo- and radiation therapy compared with Eca109 and TE-1 cells in vitro. Furthermore, western blotting and immunofluorescence showed that the expression of PI3K, P-Ak were significantly (P<0.001) increased in Eca109-psb and TE-1-psb cells compared to control Eca109 and TE-1 cells. While by using LY294002, a specific PI3K inhibitor, the high expressions of PI3Kand P-Ak were significantly reversed in Eca109-psb and TE-1-psb cells. The xenograft nude mouse model showed that both Eca109-psb and TE-1-psb cells had higher tumorigenesis abilities as well as higher expressions of PI3K, Akt and P-Ak proteins compared with Eca109 and TE-1 cells in vivo. In conclusion, the present study demonstrated that HPV16 E6-E7 promotes CSCs phenotype and chemo-radioresistance in ESCC cells through the activation of PI3K/Akt signaling pathway. Targeting the PI3K/Akt signaling pathway in HPV16 positive ESCC patients may be an alternative therapeutic method.